Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2021
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2020
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [3]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NMD Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Zero Leprosy Toolkit
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Oskam L
  • BMC medical genetics
  • Heterozygote

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (1)

Publication Type

  • Article (1)

Author/Contributor

  • Schuring RP (1)
  • (-) Oskam L (1)
  • Hamann L (1)
  • Schumann RR (1)
  • Alpsoy E (1)
  • Kumpf O (1)
  • Bedu-Addo G (1)
  • Bienzle U (1)
  • Mockenhaupt FP (1)

Journal

  • (-) BMC medical genetics (1)

Year of Publication

  • 2021 (34)
  • 2020 (1363)
  • 2019 (1198)
  • 2018 (1170)
  • 2017 (1239)
  • 2016 (1373)
  • 2015 (1068)
  • 2014 (893)
  • 2013 (854)
  • 2012 (652)
  • 2011 (597)
  • 2010 (562)
  • 2009 (589)
  • 2008 (550)
  • 2007 (460)
  • 2006 (443)
  • 2005 (443)
  • 2004 (480)
  • 2003 (463)
  • 2002 (389)
  • 2001 (394)
  • 2000 (428)
  • 1999 (443)
  • 1998 (452)
  • 1997 (419)
  • 1996 (412)
  • 1995 (454)
  • 1994 (493)
  • 1993 (477)
  • 1992 (501)
  • 1991 (490)
  • 1990 (511)
  • 1989 (529)
  • 1988 (552)
  • 1987 (504)
  • 1986 (551)
  • 1985 (523)
  • 1984 (496)
  • 1983 (547)
  • 1982 (500)
  • 1981 (440)
  • 1980 (391)
  • 1979 (422)
  • 1978 (347)
  • 1977 (308)
  • 1976 (398)
  • 1975 (331)
  • 1974 (350)
  • 1973 (342)
  • 1972 (315)
  • 1971 (336)
  • 1970 (314)
  • 1969 (286)
  • 1968 (318)
  • 1967 (260)
  • 1966 (281)
  • 1965 (254)
  • 1964 (193)
  • 1963 (145)
  • 1962 (140)
  • 1961 (154)
  • 1960 (175)
  • 1959 (140)
  • 1958 (129)
  • 1957 (168)
  • 1956 (161)
  • 1955 (148)
  • 1954 (147)
  • 1953 (187)
  • 1952 (227)
  • 1951 (205)
  • 1950 (160)
  • 1949 (43)
  • 1948 (88)
  • 1947 (78)
  • 1946 (36)
  • 1945 (9)
  • 1944 (2)
  • 1942 (5)
  • 1941 (1)
  • 1940 (6)
  • 1939 (8)
  • 1938 (8)
  • 1937 (7)
  • 1936 (24)
  • 1935 (6)
  • 1934 (12)
  • 1933 (12)
  • 1932 (7)
  • 1931 (6)
  • 1930 (7)
  • 1929 (11)
  • 1928 (2)
  • 1927 (6)
  • 1926 (8)
  • 1925 (9)
  • 1924 (8)
  • 1923 (2)
  • 1922 (4)
  • 1921 (2)
  • 1920 (4)
  • 1919 (1)
  • 1917 (1)
  • 1916 (2)
  • 1915 (4)
  • 1914 (6)
  • 1913 (2)
  • 1912 (4)
  • 1911 (11)
  • 1910 (6)
  • 1909 (5)
  • 1908 (4)
  • 1907 (1)
  • 1906 (3)
  • 1905 (1)
  • 1904 (4)
  • 1903 (1)
  • 1902 (5)
  • 1901 (2)
  • 1899 (1)
  • 1898 (4)
  • 1897 (4)
  • 1896 (1)
  • 1895 (2)
  • 1893 (2)
  • 1892 (3)
  • 1891 (2)
  • 1890 (7)
  • 1889 (9)
  • 1888 (1)
  • 1886 (1)
  • 1883 (1)
  • 1881 (1)
  • 1880 (1)
  • 1879 (3)
  • 1878 (1)
  • 1877 (3)
  • 1876 (2)
  • 1875 (3)
  • 1874 (1)
  • 1873 (1)
  • 1872 (1)
  • 1870 (4)
  • 1868 (1)
  • 1867 (1)
  • 1866 (1)
  • 1864 (1)
  • 1863 (1)
  • 1861 (1)
  • 1857 (1)
  • 1855 (1)
  • 1847 (1)
  • 1800 (1)
  • 1765 (1)
  • 2 (1)
  • 0 (153)

Language

  • English (1)

Research Group

  • LRI / Leprosy Research Initiative
  • IDEAL
  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018)
  • SARI Project (2010-2016)
  • KIT / Treatment of Early Neuropathy in Leprosy Trial (TENLEP) (2010-2016)
  • LSHTM / Development & validation severity scale ENL May 2015 - April 2017
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019)
  • AMC / Role of complement system in nerve damage (2011-2014)
  • LUMC / Immunopathology of leprosy, follow up (2011-2015)
  • Enablement / Inclusion of people with physical disabilities in Nepal
  • LWM / Macro and micro epidemiology of leprosy in Cebu
 
Relevance
Date
1 items

Publication

Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy.

Hamann L, Kumpf O, Schuring RP, et al. BMC medical genetics. 2009;

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • About Infolep
  • Privacy statement
  • FAQ
  • Contact

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2021 Infolep